Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
US FDA May Start To Miss User Fee Deadlines
Apr 17 2020
•
By
M. Nielsen Hobbs
The US FDA's product review engine is still running despite the strain of COVID-19, but it's starting to overheat.
More from Product Reviews
More from Pink Sheet